Fibroblast growth factor 21 night watch: advances and uncertainties in the field
Particularly, bromocriptine-Quick Release has been found to decrease plasma glucose levels and improve glucose tolerance in both diabetic and nondiabetic subjects (34, 35, 38)
Early retrospective analyses in women with PCOS suggest more pronounced improvements in testosterone and cycle regularity compared to semaglutide equivalents, but prospective confirmation is needed
Materials (Basel) 17:117 Re R, Pellegrini N, Proteggente A et al (1999) Antioxidant activity applying an improved ABTS radical cation decolorization assay
and diminish the nephrotoxic effects of the chemotherapy drug cisplatin (Harisa 2013)
So, if you've been prescribed Ozempic for weight loss outside of diabetes care, its considered off-label use